Intelligence · Clinical Pipeline
AXIM Biotechnologies Pipeline
All ClinicalTrials.gov programs at AXIM Biotechnologies — phase, modality, and trial IDs.
- Programs
- 5
Quick answer
AXIM Biotechnologies has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Chewing Gum
AXIM BIOTECHNOLOGIES, INC.
THC
1 trial -
ONC206 Powder
AXIM BIOTECHNOLOGIES, INC.
Diffuse Midline Glioma (DMG), and Other Recurrent Primary Malignant Central Nervous System (CNS) Tumors
1 trial -
Vyxeos Liposomal 44 mg/100 mg powder for concentrate for solution for infusion., Evoltra 1 mg/ml concentrate for solution for infusion
AXIM BIOTECHNOLOGIES, INC.
AML
1 trial -
WT1-loaded CBDC Vaccine
AXIM BIOTECHNOLOGIES, INC.
AML: Acute Myeloid Leukemia/ cancer of blood and bone marrow
1 trial -
Ziftomenib, Ziftomenib, Cytarabine 20 mg/ml Solution for Injection/Infusion, Fludarabine phosphate 25 mg/ml Concentrate for Solution for Injection or Infusion, Ziftomenib, Cytarabine 20 mg/ml Solution for Injection/Infusion, Solu-Cortef Powder for Solution for Injection or Infusion 100 mg
AXIM BIOTECHNOLOGIES, INC.
Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia, Acute Lymphocytic Leukemia
1 trial
Frequently asked questions
How many pipeline programs does AXIM Biotechnologies have?
5 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs